You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
遠大醫藥(00512.HK):全球創新眼科藥物CBT-001國際多中心III期臨牀試驗完成全部患者入組

格隆匯6月4日丨遠大醫藥(00512.HK)發佈公告,集團用於治療翼狀胬肉的全球創新眼科藥物CBT-001(GPN00153)開展的國際多中心III期臨牀試驗,近日完成了全球中心全部患者入組。該研究是一項隨機、雙盲、安慰劑平行對照的III期臨牀試驗,擬入組660例12週歲及以上的翼狀胬肉伴結膜充血患者,旨在評估CBT-001滴眼液在減少結膜充血和預防翼狀胬肉進展方面的安全性和有效性。此次,該產品臨牀研究全部患者入組是本集團在五官科領域眼科方向的又一次重大里程碑進展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account